Home Alliance Magazine
Analysis
Philanthropists are funding drug research the wrong way
Almost every pound spent by public and philanthropic actors on cancer and other disease-focused R&D will ultimately end up as intellectual property owned and ruthlessly controlled by drug companies
Read moreEditor’s picks
Latest
For subscribers
Unlock content
Analysis
Football’s past, present and future are dependent on philanthropy
As Europe’s concentration turns to football, Alliance looks at the role philanthropy has played shaping the game
Analysis
Arts funding post-Covid is on life support
Watching Sir Captain Tom walk his garden during Covid, I recall thinking to myself – I know when we started fundraising for culture, but when did we start fundraising for the NHS?
